FBXW8 is upregulated in hepatocellular carcinoma and promotes HCC cell malignancy

Duanzhuo Li, Yanli Liao, Silin Yao, Hangzhi Li, Yi quan, Mi Huang

Open source

DOI
10.1186/s12876-026-05146-0
Published
2026-07-17
Container
BMC Gastroenterology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12876-026-05146-0,
  title = {FBXW8 is upregulated in hepatocellular carcinoma and promotes HCC cell malignancy},
  author = {Duanzhuo Li and Yanli Liao and Silin Yao and Hangzhi Li and Yi quan and Mi Huang},
  year = {2026},
  journal = {BMC Gastroenterology},
  doi = {10.1186/s12876-026-05146-0},
  url = {https://doi.org/10.1186/s12876-026-05146-0}
}

RIS

TY  - JOUR
TI  - FBXW8 is upregulated in hepatocellular carcinoma and promotes HCC cell malignancy
AU  - Duanzhuo Li
AU  - Yanli Liao
AU  - Silin Yao
AU  - Hangzhi Li
AU  - Yi quan
AU  - Mi Huang
PY  - 2026
JO  - BMC Gastroenterology
DO  - 10.1186/s12876-026-05146-0
UR  - https://doi.org/10.1186/s12876-026-05146-0
ER  - 

APA

Li, D., Liao, Y., Yao, S., Li, H., quan, Y., & Huang, M. (2026). FBXW8 is upregulated in hepatocellular carcinoma and promotes HCC cell malignancy. BMC Gastroenterology. https://doi.org/10.1186/s12876-026-05146-0

Source records